Aktuelle Fragen des med.-wiss. Publikationswesens (Teil 4)

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Siehe auch
Freie Übersichtsartikel

[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99][100][101][102][103][104][105][106][107][108][109][110][111][112][113][114][115][116][117][118][119][120][121][122][123][124][125][126][127][128][129][130][131][132][133][134][135][136][137][138][139][140][141][142][143][144][145][146][147][148][149][150][151][152][153][154][155][156][157][158][159][160][161][162][163][164]


Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

Bibliographie

  1. ↑ Characteristics of and trends in the late-stage biopharmaceutical pipeline. Am J Manag Care 14(4):226-9 (2008) PMID 18402515
  2. ↑ Primum non nocere: does the current research publication system (or the lay press) harm our patients? Am J Respir Crit Care Med 171(9):937-8 (2005) PMID 15849326
  3. ↑ Mentoring: seven roles and some specifics. Am J Respir Crit Care Med 170(2):114-7 (2004) PMID 15242852
  4. ↑ Assessing the performance of a medical journal. Am J Respir Crit Care Med 169(12):1268-72 (2004) PMID 15187009
  5. ↑ Financial disclosure of reviewers. Am J Respir Crit Care Med 168(8):1010; author reply 1010 (2003) PMID 14555459
  6. ↑ Peer review and manuscript triage. Am J Respir Crit Care Med 168(3):397; author reply 397; discussion 397-8 (2003) PMID 12888612
  7. ↑ How I review an original scientific article. Am J Respir Crit Care Med 166(8):1019-23 (2002) PMID 12379542
  8. ↑ Rigor of peer review and the standing of a journal. Am J Respir Crit Care Med 166(8):1013-4 (2002) PMID 12379538
  9. ↑ Reporting research, retraction of results, and responsibility. Am J Respir Crit Care Med 162(3 Pt 1):773-4 (2000) PMID 10988078
  10. ↑ The shifting sands of research ethics and governance: effect on research in paediatrics. Arch Dis Child 92(1):80-1 (2007) PMID 17185448
  11. ↑ Trial registration, the ICMJE statement, and paediatric journals. Arch Dis Child 91(1):93 (2006) PMID 16374925
  12. ↑ The implications of the David Glass case for future clinical practice in the UK. Arch Dis Child 90(8):822-5 (2005) PMID 16040880
  13. ↑ How international are leading general paediatric journals? Arch Dis Child 90(8):816-7 (2005) PMID 16040877
  14. ↑ Copies of clinic letters to the family. Arch Dis Child 89(11):1032-3 (2004) PMID 15499057
  15. ↑ Towards evidence based medicine for paediatricians. Arch Dis Child 89(3):286-7 (2004) PMID 14977717
  16. ↑ Do presenters to paediatric meetings get their work published? Arch Dis Child 83(6):524-6 (2000) PMID 11087295
  17. ↑ Presenting a scientific paper, including the pitfalls. Arch Dis Child 73(2):168-9 (1995) PMID 7574867
  18. ↑ Reviewing scientific papers. Arch Dis Child 72(6):539-40 (1995) PMID 7618945
  19. ↑ Some reservations about clinical guidelines. Arch Dis Child 72(1):70-5 (1995) PMID 7717747
  20. ↑ Guidelines for ethical conduct of medical research in children. Arch Dis Child 71(3):282 (1994) PMID 7979513
  21. ↑ Duplicate publication and related problems. Arch Dis Child 65(12):1289-90 (1990) PMID 2270934
  22. ↑ Educating medical students about death and dying. Arch Dis Child 64(5):750-3 (1989) PMID 2658857
  23. ↑ Have parents the right to see their children's medical reports? Arch Dis Child 59(7):601-2 (1984) PMID 6465926
  24. ↑ The ethics of research involving children as controls. Arch Dis Child 48(10):751-2 (1973) PMID 4749679
  25. ↑ Peer review. Cost control or quality control? Calif Med 113(6):75-80 (1970) PMID 5486540
  26. ↑ Utilization and peer review. Medicine's privilege and responsibility. Calif Med 113(2):80-5 (1970) PMID 5527892
  27. ↑ Editorial: Peer review. Calif Med 113(2):69-70 (1970) PMID 5527886
  28. ↑ Peer Review. Calif Med 112(2):77-78 (1970) PMID 18730260
  29. ↑ Scientific editorials--a precious and scarce element in medical journals. Can Med Assoc J 132(4):315 (1985) PMID 3971245
  30. ↑ How books and journals will survive the electronic revolution. Can Med Assoc J 132(3):232 (1985) PMID 3967155
  31. ↑ Originality, novelty and priority: three words to reckon with in scientific publishing. Can Med Assoc J 132(1):8-9 (1985) PMID 3965061
  32. ↑ The randomized clinical trial: panacea or placebo? Can Med Assoc J 131(11):1336-9 (1984) PMID 6498685
  33. ↑ Could there be a conspiracy to suppress valid treatments of disease? Can Med Assoc J 130(1):15-6 (1984) PMID 6689987
  34. ↑ Author, editor and reviewer: how manuscripts become journal articles. Can Med Assoc J 124(6):664-6 (1981) PMID 7471010
  35. ↑ Peer review and scientific method in clinical research. Can Med Assoc J 124(3):251-3 (1981) PMID 7459784
  36. ↑ Guidelines: what are they and how will they be used? Can Med Assoc J 115(9):937-43 (1976) PMID 991039
  37. ↑ Scientific and medical journals: obsolete or overgrown. Can Med Assoc J 115(8):714-5 (1976) PMID 974959
  38. ↑ CURRENT PEER REVIEW SYSTEMS: A PROBLEM FOR INNOVATIVE APPROACHES IN SCIENCE. Cardiovasc Dis 1(2):67-69 (1974) PMID 15215984
  39. ↑ When does previous disclosure become a 'prior publication' problem? Chest 135(1):233-7 (2009) PMID 19136413
  40. ↑ How many unjustifiable lectures are worth $2.4 billion? Chest 134(6):1117-20 (2008) PMID 19059955
  41. ↑ Abstracts for professional meetings: small but mighty. Chest 134(5):1103-5 (2008) PMID 18988788
  42. ↑ At a glance: a stepwise approach to successful poster presentations. Chest 134(2):457-9 (2008) PMID 18682467
  43. ↑ Keep attendees awake: writing effective presentations for international conferences. Chest 134(1):204-6 (2008) PMID 18628227
  44. ↑ All the sourcing not fit to print: citing electronic material in your article. Chest 133(6):1524-6 (2008) PMID 18574300
  45. ↑ How to choose the right journal for your manuscript. Chest 132(3):1073-6 (2007) PMID 17873202
  46. ↑ Guidelines for guidelines: we've come a long way. Chest 132(3):746-7 (2007) PMID 17873187
  47. ↑ Avoiding common problems during online submission of manuscripts. Chest 131(5):1591-4 (2007) PMID 17494812
  48. ↑ Journal reporting of medical errors: the wisdom of Solomon, the bravery of Achilles, and the foolishness of Pan. Chest 131(3):890-6 (2007) PMID 17356109
  49. ↑ Clinical trial registration promotes patient protection and benefit, advances the trust of everyone, and is required. Chest 131(3):639-41 (2007) PMID 17356071
  50. ↑ Registering a clinical trial in ClinicalTrials.gov. Chest 131(3):909-12 (2007) PMID 17303677
  51. ↑ Writing an application for a human subjects institutional review board. Chest 130(5):1605-7 (2006) PMID 17099043
  52. ↑ Writing successful grant applications for preclinical studies. Chest 130(1):296-8 (2006) PMID 16840416
  53. ↑ Should editorials in peer-reviewed journals be signed? Chest 129(6):1395-6 (2006) PMID 16778248
  54. ↑ Some concrete ideas about manuscript abstracts. Chest 129(5):1375-7 (2006) PMID 16685031
  55. ↑ The uniform requirements for manuscripts submitted to biomedical journals recommended by the International Committee of Medical Journal Editors. Chest 129(4):1098-9 (2006) PMID 16608962
  56. ↑ Preparing manuscripts for online submission: basic information and avoidance of common pitfalls. Chest 129(3):822-5 (2006) PMID 16537888
  57. ↑ The NIH Public Access Policy: CHEST's position and concerns regarding the responsibilities of the NIH principle investigator. Chest 127(5):1471-2 (2005) PMID 15888810
  58. ↑ Physician killed by ducks. Chest 127(3):695-6 (2005) PMID 15764740
  59. ↑ Why do physicians who treat lung cancer get sued? Chest 126(5):1672-9 (2004) PMID 15539742
  60. ↑ Ethical assessment of industry-sponsored clinical trials: a case analysis. Chest 121(4):1337-42 (2002) PMID 11948071
  61. ↑ Physicians' learning strategies. Chest 118(2 Suppl):18S-23S (2000) PMID 10939995
  62. ↑ Evidence for the effectiveness of techniques To change physician behavior. Chest 118(2 Suppl):8S-17S (2000) PMID 10939994
  63. ↑ Too many journals, too little time. Chest 118(1):1 (2000) PMID 10893345
  64. ↑ Publishing supplements. Chest 117(4):927-8 (2000) PMID 10767216
  65. ↑ The barbarism of managed care. Chest 110(1):1-2 (1996) PMID 8681610
  66. ↑ The education of a physician. Chest 106(5):1313 (1994) PMID 7956372
  67. ↑ What constitutes prior publication? Chest 92(1):2-3 (1987) PMID 3595244
  68. ↑ Peer review in medical journals. Chest 91(2):252-7 (1987) PMID 3802937
  69. ↑ Modems and the M.D. The microcomputer as a communications tool. Chest 87(1):4-5 (1985) PMID 3965264
  70. ↑ Free medical publications or scientific medical journals. Chest 81(4):397-8 (1982) PMID 7067502
  71. ↑ Identification of reviewers: a statement of policy. Chest 75(3):295-6 (1979) PMID 421568
  72. ↑ Clinical trials and the drug review process. Chest 73(6 Suppl):967-71 (1978) PMID 354887
  73. ↑ Editorial: Books and computer tape, journals and microfiche--who shall pay? Chest 67(6):629-30 (1975) PMID 1126216
  74. ↑ Taboo: crossing the specialty barrier. Eur Respir J 31(6):1153-4 (2008) PMID 18515554
  75. ↑ The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level. Eur Respir J 31(5):924-6 (2008) PMID 18448501
  76. ↑ Evidence-based medicines for children: Important implications for new therapies at all ages. Eur Respir J 28(6):1069-72 (2006) PMID 17138673
  77. ↑ Excess mortality in patients with asthma on long-acting beta2-agonists. Eur Respir J 28(5):900-2 (2006) PMID 17074917
  78. ↑ Publishing collaborative studies between academics and industry. Eur Respir J 10(11):2441-2 (1997) PMID 9426074
  79. ↑ Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship. Isr Med Assoc J 8(7):451-4 (2006) PMID 16889157
  80. ↑ Compensation for research-related injury. J Postgrad Med 55(2):87-8 (2009) PMID 19550049
  81. ↑ Incentives to encourage peer review. J Postgrad Med 52(4):325 (2006) PMID 17102563
  82. ↑ Research trials: registration, reporting and publication. J Postgrad Med 51(2):83-4 (2005) PMID 16006696
  83. ↑ Confusing brand names: nightmare of medical profession. J Postgrad Med 51(1):13-6 (2005) PMID 15793332
  84. ↑ From the pen to the patient: minimising medication errors. J Postgrad Med 51(1):3-4 (2005) PMID 15793329
  85. ↑ Open access to peer-reviewed research through author/institution self-archiving: maximizing research impact by maximizing online access. J Postgrad Med 49(4):337-42 (2003) PMID 14699234
  86. ↑ A few steps towards responsible authorship (and editorship). J Postgrad Med 47(4):233-4 (2001) PMID 11832636
  87. ↑ Peer review -- process, perspectives and the path ahead. J Postgrad Med 47(3):210-4 (2001) PMID 11832629
  88. ↑ ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice. J Postgrad Med 47(3):199-203 (2001) PMID 11832625
  89. ↑ ICH Harmonised Tripartite Guideline: guideline for good clinical practice. J Postgrad Med 47(2):121-30 (2001) PMID 11832605
  90. ↑ ICH harmonized tripartite guideline: Guideline for Good Clinical Practice. J Postgrad Med 47(1):45-50 (2001) PMID 11590294
  91. ↑ Duplicate and salami publications. J Postgrad Med 46(2):67-9 (2000) PMID 11013467
  92. ↑ Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals. Mayo Clin Proc 84(9):811-21 (2009) PMID 19720779
  93. ↑ The business of providing high-quality content to Mayo Clinic Proceedings' readers: 2009 and beyond. Mayo Clin Proc 84(1):7-10 (2009) PMID 19121247
  94. ↑ Editor's note: Industry support of articles published in Mayo Clinic Proceedings. Mayo Clin Proc 81(6):851-2 (2006) PMID 16832914
  95. ↑ Rounding alone: assessing the value of grand rounds in contemporary departments of medicine. Mayo Clin Proc 78(5):547-8 (2003) PMID 12744539
  96. ↑ Searching the medical literature using PubMed: a tutorial. Mayo Clin Proc 78(1):87-91 (2003) PMID 12528881
  97. ↑ Identifying and addressing safety signals in clinical trials. N Engl J Med 359(13):1400-2 (2008) PMID 18768938
  98. ↑ Drug-review deadlines and safety problems. N Engl J Med 358(13):1354-61 (2008) PMID 18367738
  99. ↑ Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358(3):252-60 (2008) PMID 18199864
  100. ↑ Financial relationships between institutional review board members and industry. N Engl J Med 355(22):2321-9 (2006) PMID 17135585
  101. ↑ Trial Registration at ClinicalTrials.gov between May and October 2005. N Engl J Med 353(26):2779-87 (2005) PMID 16382064
  102. ↑ A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med 347(17):1335-41 (2002) PMID 12397192
  103. ↑ A national survey of policies on disclosure of conflicts of interest in biomedical research. N Engl J Med 343(22):1621-6 (2000) PMID 11096171
  104. ↑ Conflict-of-interest policies for investigators in clinical trials. N Engl J Med 343(22):1616-20 (2000) PMID 11096170
  105. ↑ The use of the World Wide Web by medical journals in 2003 and 2005: an observational study. Pediatrics 119(1):e53-60 (2007) PMID 17200258
  106. ↑ Are research ethics standards satisfied in pediatric journal publications? Pediatrics 110(2 Pt 1):364-70 (2002) PMID 12165592
  107. ↑ Marketing data: has the rise of impact factor led to the fall of objective language in the scientific article? Respir Res 10():35 (2009) PMID 19432970
  108. ↑ Getting grant applications funded: lessons from the past and advice for the future. Thorax 59(12):1010-1 (2004) PMID 15563696
  109. ↑ Duplicate publication, redundant publication, and disclosure of closely related publications. Thorax 54(5):378 (1999) PMID 10212097
  110. ↑ Improving the chances of successful research funding. Thorax 41(11):817-21 (1986) PMID 3824266
  111. ↑ Lies, damned lies, and statistics. J Am Coll Cardiol 52(17):1430-1 (2008) PMID 18940535
  112. ↑ How do I get a paper accepted? Concerns of a junior researcher. J Am Coll Cardiol 50(23):2263; author reply 2263 (2007) PMID 18061076
  113. ↑ How do I get a paper accepted?--Part 2. J Am Coll Cardiol 49(19):1989-90 (2007) PMID 17498585
  114. ↑ How do I get a paper accepted? J Am Coll Cardiol 49(15):1666-7 (2007) PMID 17433960
  115. ↑ Philanthropy and medicine. J Am Coll Cardiol 48(8):1725-6 (2006) PMID 17045912
  116. ↑ An open letter to reviewers (or to anyone whose solicited recommendation has not been followed). J Am Coll Cardiol 48(2):409-10 (2006) PMID 16843195
  117. ↑ Conflation of empiric and nonempiric truths in cardiovascular guidelines. J Am Coll Cardiol 45(9):1551 (2005) PMID 15862438
  118. ↑ Major meetings and the phenomenon of late-breaking clinical trials. J Am Coll Cardiol 45(8):1304-5 (2005) PMID 15837267
  119. ↑ Should the lack of feasibility of conducting controlled trials influence evidence-based guidelines? J Am Coll Cardiol 45(5):810-1; author reply 811 (2005) PMID 15734635
  120. ↑ Open access, open archives, and enhanced public access to National Institutes of Health Research. J Am Coll Cardiol 44(12):2406-7 (2004) PMID 15607405
  121. ↑ Publication bias and journals as policemen. J Am Coll Cardiol 44(8):1707-8 (2004) PMID 15489107
  122. ↑ Characteristics of a great review. J Am Coll Cardiol 43(10):1927 (2004) PMID 15145127
  123. ↑ Authors, industry, and review articles. J Am Coll Cardiol 43(6):1130-1 (2004) PMID 15028380
  124. ↑ What constitutes a great review? J Am Coll Cardiol 42(7):1314-5 (2003) PMID 14522501
  125. ↑ The power of clinical trials and guidelines,and the challenge of conflicts of interest. J Am Coll Cardiol 41(8):1237-42 (2003) PMID 12706915
  126. ↑ Duplicate publication: insights into the essence of a medical journal. J Am Coll Cardiol 41(3):516-7 (2003) PMID 12575985
  127. ↑ The elite reviewer. J Am Coll Cardiol 41(1):157-8 (2003) PMID 12570959
  128. ↑ Peer review: better than the alternatives. J Am Coll Cardiol 40(5):1017-8 (2002) PMID 12225731
  129. ↑ Why did JACC reject my manuscript? Journal of the American College of Cardiology. J Am Coll Cardiol 37(1):323-4 (2001) PMID 11153759
  130. ↑ Full disclosure: the antidote to conflict of interest. J Am Coll Cardiol 35(6):1693 (2000) PMID 10807478
  131. ↑ Editorial independence--what did we learn from the Journal of the American Medical Association? J Am Coll Cardiol 33(7):2083-4 (1999) PMID 10362218
  132. ↑ What's new in peer review? J Am Coll Cardiol 32(7):2098-9 (1998) PMID 9857900
  133. ↑ To publish or not to publish: that is the question. J Am Coll Cardiol 32(5):1468 (1998) PMID 9809965
  134. ↑ Medical Editors Trial Amnesty (META) J Am Coll Cardiol 31(1):236 (1998) PMID 9426046
  135. ↑ We've got to stop meeting like this! J Am Coll Cardiol 29(2):455-6 (1997) PMID 9015004
  136. ↑ Peer review or poor review? J Am Coll Cardiol 25(6):1470-1 (1995) PMID 7722151
  137. ↑ Drug discovery in academia. Am J Physiol Cell Physiol 286(3):C465-74 (2004) PMID 14761879
  138. ↑ Impact factors and the competitive nature of journal publishing. Am J Physiol Heart Circ Physiol 279(2):H457 (2000) PMID 10991631
  139. ↑ Publishing in the journals of the APS: why are authors charged fees? Am J Physiol Heart Circ Physiol 278(5):H1409-10 (2000) PMID 10775115
  140. ↑ Training the clinician investigator. Circ Res 103(8):771-2 (2008) PMID 18845813
  141. ↑ Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Circ Res 96(5):600-1 (2005) PMID 15774862
  142. ↑ The impact of a journal and its editor on a career in experimental cardiology. Circ Res 92(10):1057-8 (2003) PMID 12775652
  143. ↑ A second term for the editors. Status and goals for the review process. Circ Res 79(1):1-3 (1996) PMID 8925556
  144. ↑ Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 118(12):1294-303 (2008) PMID 18794402
  145. ↑ Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease. Circulation 116(16):1845-54 (2007) PMID 17938301
  146. ↑ Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Circulation 111(10):1337-8 (2005) PMID 15769778
  147. ↑ Should evidence-based proof of efficacy as defined for a specific therapeutic agent be extrapolated to encompass a therapeutic class of agents? Circulation 108(21):2604-7 (2003) PMID 14638523
  148. ↑ Paying for clinical trials. Circulation 102(9):E9016-7 (2000) PMID 10961982
  149. ↑ Medical Practice Guidelines. Separating science from economics. Eur Heart J 24(21):1962-4 (2003) PMID 14585255
  150. ↑ Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics. Eur J Hum Genet 16 Suppl 1():S10-9 (2008) PMID 18432281
  151. ↑ Patenting and licensing in genetic testing. Eur J Hum Genet 16(4):405-11 (2008) PMID 18354424
  152. ↑ The emergence of an ethical duty to disclose genetic research results: international perspectives. Eur J Hum Genet 14(11):1170-8 (2006) PMID 16868560
  153. ↑ A review of international and UK-based ethical guidelines for researchers conducting nontherapeutic genetic studies in developing countries. Eur J Hum Genet 14(1):9-16 (2006) PMID 16175190
  154. ↑ Translational research: advancing medical science by stimulating interdisciplinary research. Exp Biol Med (Maywood) 232(6):713-4 (2007) PMID 17526762
  155. ↑ Nobel round-table discussion #2: conflicts of interest, scientific misconduct, fair sharing, and intellectual property in an interdisciplinary/inter-institutional consortium. Exp Biol Med (Maywood) 231(7):1240-54 (2006) PMID 16816129
  156. ↑ Nobel round-table discussion #1: the future of interdisciplinary research and training. Exp Biol Med (Maywood) 231(7):1225-39 (2006) PMID 16816128
  157. ↑ Evidence-based medicine and the need for non-commercial clinical research directed towards therapeutic innovation. Exp Biol Med (Maywood) 227(7):435-7 (2002) PMID 12094006
  158. ↑ Clinical investigation: but why? Exp Biol Med (Maywood) 226(10):871-2 (2001) PMID 11682692
  159. ↑ Crises in academic medicine. Exp Biol Med (Maywood) 226(4):239-42 (2001) PMID 11368416
  160. ↑ Teaching how to prepare a manuscript by means of rewriting published scientific papers. Genetics 175(1):17-20 (2007) PMID 17110479
  161. ↑ Current and future relevance of guidelines. Heart 87(6):497-500 (2002) PMID 12010924
  162. ↑ Ethics in research. Proc Soc Exp Biol Med 224(4):205-10 (2000) PMID 10964253
  163. ↑ Introduction: Forum on Responsible Conduct in Biomedical Research. Proc Soc Exp Biol Med 224(4):203-4 (2000) PMID 10964252
  164. ↑ Hyposkillia: deficiency of clinical skills. Tex Heart Inst J 32(3):255-7 (2005) PMID 16392201
Abgerufen von „http://de.pluspedia.org/w/index.php?title=Aktuelle_Fragen_des_med.-wiss._Publikationswesens_(Teil_4)&oldid=951342“

Diesen Artikel melden!
Verletzt dieser Artikel deine Urheber- oder Persönlichkeitsrechte?
Hast du einen Löschwunsch oder ein anderes Anliegen? Dann nutze bitte unser Kontaktformular

PlusPedia Impressum
Diese Seite mit Freunden teilen:
Mr Wong Digg Delicious Yiggit wikio Twitter
Facebook


Bitte Beachte:
Sämtliche Aussagen auf dieser Seite sind ohne Gewähr.
Für die Richtigkeit der Aussagen übernimmt die Betreiberin keine Verantwortung.
Nach Kenntnissnahme von Fehlern und Rechtsverstößens ist die Betreiberin selbstverständlich bereit,
diese zu beheben.

Verantwortlich für jede einzelne Aussage ist der jeweilige Erstautor dieser Aussage.
Mit dem Ergänzen und Weiterschreiben eines Artikels durch einen anderen Autor
werden die vorhergehenden Aussagen und Inhalte nicht zu eigenen.
Die Weiternutzung und Glaubhaftigkeit der Inhalte ist selbst gegenzurecherchieren.


Typo3 Besucherzähler - Seitwert blog counter
java hosting vpn norway